Orchard Therapeutics Announces Additional Interim Results from Proof-of-Concept Study of OTL-203 for MPS-I September 1, 2020
Innovent Announces First Subject Dosed in the Phase 1 Clinical Trial of Anti-IL-23 Monoclonal Antibody August 31, 2020
Innovent Announces the Results of the Phase 1/2 Clinical Study of PCSK9 Antibody Tafolecimab at the European Society of Cardiology Annual Conference August 30, 2020
EY Announces Nick Culbertson of Protenus as an Entrepreneur of the Year® 2020 Mid-Atlantic Award Finalist August 27, 2020
MedGenome announces Strategic Collaboration in Parkinson’s Disease with Denali Therapeutics August 26, 2020